Projection of long-term outcomes using X-rays and pooled cytology in lung cancer screening
Dongfeng Wu1, Diane Erwin2, Seongho Kim1
1Department of Bioinformatics and Biostatistics, School of Public Health and Information Sciences, University of Louisville, Louisville, KY, 2Information Management Services, Inc, Rockville, MD, USA
Purpose: To investigate the long-term outcome of using X-ray and the 3-day "pooled" sputum cytology in lung cancer screening using the Mayo Lung Project data.
Methods: In this study, the statistical method developed by the authors using the Mayo Lung Project data was applied. Each participant eventually falls into one of the four categories depending on whether they would be diagnosed with lung cancer and whether symptoms would have appeared before death. The derived probability of each outcome was presented. Bayesian inference was made for the percentages of true-early-detection, no-early-detection, over-diagnosis, and symptom-free-life. The authors present estimates of these proportions for male heavy smokers by using Markov Chain Monte Carlo samples in the simulation. Human lifetime was treated as a random variable.
Results: The probability that a male heavy smoker will live a lung cancer-free life is about 80%; the probability for developing lung cancer for a male heavy smoker is about 20%, much higher than in the general population (6.95%). The probability of over-diagnosis is low, about 6%–9% among the early detected cases. The probability of true-early-detection is greater than 90%. Finally, the probability of no-early-detection increases as the screening interval increases; among the diagnosed cases, it is about 15% if the screens are 6 months apart, and it is close to 50% if the screens are 2 years apart.
Conclusion: This research provides a framework and a systematic approach for policy makers regarding how to evaluate long-term outcomes of chest X-ray and pooled sputum cytology in lung cancer screening.
Keywords: true early detection, no early detection, over diagnosis, symptom-free life, pooled sputum cytology
This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php
Other article by this author:
Readers of this article also read:
Smith CN, Kraemer JD, Johnson AC, Mays D
Published Date: 2 April 2015
Physiotherapy for human T-lymphotropic virus 1-associated myelopathy: review of the literature and future perspectives
Sá KN, Macêdo MC, Andrade RP, Mendes SD, Martins JV, Baptista AF
Published Date: 23 February 2015
Plasma concentrations of fenbendazole (FBZ) and oxfendazole in alpacas (Lama pacos) after single intravenous and oral dosing of FBZ
Lakritz J, Linden D, Anderson DE, Specht TA
Published Date: 19 February 2015
Minami S, Kijima T
Published Date: 29 January 2015
Gollapalli L, Muppuri R
Published Date: 20 November 2014
Published Date: 18 November 2014
Puleo V, Castagno PL
Published Date: 9 September 2013
Photothermal response of CVD synthesized carbon (nano)spheres/aqueous nanofluids for potential application in direct solar absorption collectors: a preliminary investigation
Poinern GE, Brundavanam S, Shah M, Laava I, Fawcett D
Published Date: 30 July 2012
Pearson KC, Armstrong AW
Published Date: 13 January 2012